COPD-iNET: 呼吁肺病界采取行动，抗击 COPD 在全球的流行

IF 16.6 1区医学 Q1 RESPIRATORY SYSTEM

European Respiratory Journal Pub Date : 2024-09-26 DOI:10.1183/13993003.00921-2024

Ali Önder Yildirim, Thomas M. Conlon, Ian M. Adcock, Reinoud Gosens, Mareike Lehmann, Theodore S. Kapellos, Yohannes Tesfaigzi, Francesca Polverino, Maor Sauler, Roxana Wasnick, Enid Rose Neptune

{"title":"COPD-iNET: 呼吁肺病界采取行动，抗击 COPD 在全球的流行","authors":"Ali Önder Yildirim, Thomas M. Conlon, Ian M. Adcock, Reinoud Gosens, Mareike Lehmann, Theodore S. Kapellos, Yohannes Tesfaigzi, Francesca Polverino, Maor Sauler, Roxana Wasnick, Enid Rose Neptune","doi":"10.1183/13993003.00921-2024","DOIUrl":null,"url":null,"abstract":"<sec><st>Extract</st>\n<p>COPD is an increasingly prevalent, progressive and often debilitating lung disease, currently the third leading cause of death globally. While commonly considered a disease of smokers, common causes of COPD also include environmental pollution, infection, pre- and peri-natal life insults, and genetic predisposition [1, 2]. Current therapies are limited to reducing the burden of symptoms or exacerbations, but do not fundamentally alter the trajectory of the disease.</p>\n</sec>","PeriodicalId":12265,"journal":{"name":"European Respiratory Journal","volume":"8 1","pages":""},"PeriodicalIF":16.6000,"publicationDate":"2024-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"COPD-iNET: a call to the lung community for action to combat the global epidemic of COPD\",\"authors\":\"Ali Önder Yildirim, Thomas M. Conlon, Ian M. Adcock, Reinoud Gosens, Mareike Lehmann, Theodore S. Kapellos, Yohannes Tesfaigzi, Francesca Polverino, Maor Sauler, Roxana Wasnick, Enid Rose Neptune\",\"doi\":\"10.1183/13993003.00921-2024\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<sec><st>Extract</st>\\n<p>COPD is an increasingly prevalent, progressive and often debilitating lung disease, currently the third leading cause of death globally. While commonly considered a disease of smokers, common causes of COPD also include environmental pollution, infection, pre- and peri-natal life insults, and genetic predisposition [1, 2]. Current therapies are limited to reducing the burden of symptoms or exacerbations, but do not fundamentally alter the trajectory of the disease.</p>\\n</sec>\",\"PeriodicalId\":12265,\"journal\":{\"name\":\"European Respiratory Journal\",\"volume\":\"8 1\",\"pages\":\"\"},\"PeriodicalIF\":16.6000,\"publicationDate\":\"2024-09-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Respiratory Journal\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1183/13993003.00921-2024\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"RESPIRATORY SYSTEM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Respiratory Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1183/13993003.00921-2024","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}

引用次数: 0

摘要

摘要慢性阻塞性肺病是一种发病率越来越高、渐进性且常常使人衰弱的肺部疾病，目前是全球第三大死亡原因。虽然慢性阻塞性肺病通常被认为是吸烟者的疾病，但其常见病因还包括环境污染、感染、产前和围产期的生活损伤以及遗传易感性[1, 2]。目前的疗法仅限于减轻症状或病情加重的负担，并不能从根本上改变疾病的发展轨迹。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

COPD-iNET: a call to the lung community for action to combat the global epidemic of COPD

Extract

COPD is an increasingly prevalent, progressive and often debilitating lung disease, currently the third leading cause of death globally. While commonly considered a disease of smokers, common causes of COPD also include environmental pollution, infection, pre- and peri-natal life insults, and genetic predisposition [1, 2]. Current therapies are limited to reducing the burden of symptoms or exacerbations, but do not fundamentally alter the trajectory of the disease.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

European Respiratory Journal 医学-呼吸系统

CiteScore

27.50

自引率

3.30%

发文量

345

审稿时长

2-4 weeks

期刊介绍： The European Respiratory Journal (ERJ) is the flagship journal of the European Respiratory Society. It has a current impact factor of 24.9. The journal covers various aspects of adult and paediatric respiratory medicine, including cell biology, epidemiology, immunology, oncology, pathophysiology, imaging, occupational medicine, intensive care, sleep medicine, and thoracic surgery. In addition to original research material, the ERJ publishes editorial commentaries, reviews, short research letters, and correspondence to the editor. The articles are published continuously and collected into 12 monthly issues in two volumes per year.